Cerenovus
Financial Advisory, Valuation & Restructuring
Overview
Cerenovus runs company-wide operating analysis for private equity, consulting, corporate development, and advisory teams.
Funding and backers
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2026
Went through Y Combinator
2026
Founded
Feb 8, 2022
Launched Cerenovus launches Emboguard balloon catheter in US and Canada · bioworld.com
Jul 26, 2018
Launched CERENOVUS announces launch of novel stent retriever for treating stroke patients · NewsMedical
May 21, 2018
Certified CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke · PRNewswire
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Hacker News stories
1
best: 3 points
Registers and programsofficial lists and records that name the company
| Legal entity | Cerenovus Inc. | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Equity management, cap table software, and 409A valuations in one platform. AI-powered. Human-delivered. Trusted by 25,000+ private…
Due diligence and value creation for leading private equity firms. Quantitative methods and AI systems applied to private markets investing…
Art appraisal and advisory services with valuations for insurance, estate, and tax planning. Supporting collectors in managing, acquiring…
Private market intelligence for private equity, investment banking, corporate development, and consulting.
Grow your advisory practice with business owners.
Enduring Planet provides founder-friendly working capital and financial advisory services to climate startups and small/medium-sized…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Same group
SnowstoneStrong
snowstone.ai
| Evidence | Value | Source | Last seen |
|---|---|---|---|
| Same legal entity runs both sites | Pro plan | legal page | Oct 3, 2026 |
| Same legal entity named on both sites | Pro plan | legal page | Oct 3, 2026 |
Confidence 0.95
Shared investors
Y CombinatorVia a fund
6310 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
Johnson & Johnson (NYSE:JNJ) is reportedly considering selling its stroke care unit, Cerenovus, in a deal that could value the business at more than $1 billion. The move aligns with the company's ongoing efforts to streamline its medical technology divisi
Read more
Report
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
Read more
Report
Cerenovus hailed as Irish Medtech Company of the Year 2022
Cerenovus, which develops medical devices to treat patients who have had a stroke, got the top prize at this year's Irish Medtech Awards.
Read more
Report
Cerenovus to create 30 jobs as part of €50m investment in Galway
Company, part of the Johnson and Johnson Group, specialises in neurovascular care
Read more
Report
Cerenovus launches Emboguard balloon catheter in US and Canada
Johnson & Johnson business Cerenovus Inc. is launching a balloon guide catheter for the U.S. and Canada stroke market. The Irvine, Calif.-based company's Emboguard device is designed to remove blood clots by controlling blood flow during mechanical thromb
Read more
Report
CERENOVUS Launches Largest Global Registry to Study Stroke-Inducing Blood Clots Removed by Thrombectomy
/PRNewswire/ -- Johnson & Johnson Medical Devices Companies today announced that its CERENOVUS business has launched the single largest global registry, the...
Read more
Report
CERENOVUS Receives European Regulatory Approval For BRAVO Flow Diverter to Treat Intracranial Aneurysms.
Read more
Report
CERENOVUS announces launch of novel stent retriever for treating stroke patients
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ